HIV gene amplification meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA will hold a public meeting Sept. 26-28 in Silver Spring, Maryland to consider "the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative 'window' phase" of HIV infection, according to an Aug. 1 Federal Register notice. Topics to be discussed include the current status of techniques "for the detection of genetic sequences by amplification" and their applicability to donor screening, as well as "procedural and economic aspects" of utilizing these techniques. For more information, contact Nicholas Reuter at 301/443-1382